Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting inflammation in lower-risk MDS

9 Dec 2022

Abstract excerpt

The myelodysplastic syndromes (MDS) are a heterogeneous group of malignant hematopoietic stem cell disorders characterized by ineffective growth and differentiation of hematopoietic progenitors leading to peripheral blood cytopenias, dysplasia, and a variable risk of transformation to acute myelogenous leukemia. As most patients present with lower-risk disease, understanding the pathogenesis of ineffective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Eosinophilic Disorders and Syndromes
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36485128
DOI: 10.1182/hematology.2022000350

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting inflammation in lower-risk MDSPMID 36485128Read ↗

Inflammatory Signatures in MDS: The Missing Link Between Genetics, Microenvironment and TherapySemantic proximity Read ↗

Preclinical Efficacy of Tasquinimod in Myelodysplastic Neoplasms: Restoring Erythropoiesis and Mitigating Bone LossSemantic proximity Read ↗

Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy.Semantic proximity Read ↗

Activation of distinct inflammatory pathways in subgroups of LR-MDSSemantic proximity Read ↗

Inflammatory Signatures in MDS: The Missing Link Between Genetics, Microenvironment, and Therapy.Semantic proximity Read ↗

Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutationsSemantic proximity Read ↗

[Novel therapies for MDS and future prospects].Semantic proximity Read ↗

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.Semantic proximity Read ↗

IL-1β–mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromesSemantic proximity Read ↗

Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.Semantic proximity Read ↗

Inflammation in myelodysplastic syndrome pathogenesis.Semantic proximity Read ↗

New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.